Using no-evidence-of-disease-activity standard for patients with multiple sclerosis Maintaining no-evidence-of-disease-activity (NEDA) was difficult over time for many patients with multiple sclerosis (MS) but the measure may help gauge a patients long-term prognosis, according to a study published online by JAMA Neurology. NEDA has become a new goal for the treatment of MS and an outcome measure because of multiple and increasingly effective therapies for relapsing forms of the neurodegenerative disabling disease. But its unknown what proportion of patients with MS can be expected to maintain NEDA over time, according to the study background..... Read More - ms-uk.org/msetiology
Posted on: Tue, 23 Dec 2014 08:17:26 +0000
Trending Topics
Recently Viewed Topics
© 2015